A briefing document from the Food and Drug Administration (FDA) says that enrollment for all clinical studies of vaccines for ...

Finding a cure for colds and the flu is tricky to say the least, but new science may help you prevent them or at least ...

The burden of respiratory syncytial virus (RSV) in young children continues to be high in the United States, accord ...

COVID-19, influenza, and RSV vaccination coverage is low among nursing home residents early in the 2024 to 2025 season.

The FDA flagged at least five cases of severe or very severe RSV lower respiratory tract infections in infants immunized with ...

Physicians in PA don’t expect to see the surges they saw during the first winters of the COVID-19 pandemic, but encouraged ...

The viruses that scare me are the ones I don’t know about.” Anthony Fauci, long-time director of the National Institute ...

Postmortem RSV detection rate is reported as a percentage of RSV-positive cases among all-cause or respiratory deaths. To try to systematize the substantial variability in age group categories applied ...

Whooping cough cases in North Carolina have risen sharply in 2024. There have been close to 600 reported cases — 6.4 times ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunol ...

New York City data highlight the benefits of early administration of nirsevimab to safeguard infants from respiratory ...

While RSV is not on the CDC’s current list of Nationally Notifiable Diseases like COVID and influenza, a new rule from the ...